Search results for Myeloperoxidase Antibody

FITC Anti-Myeloperoxidase antibody [2C7], Abcam, AB11729

What is this antibody validated in? FITC Anti-Myeloperoxidase antibody [2C7] (ab11729) is a mouse monoclonal antibody and is validated for use in Flow Cytometry (Intra), Flow Cytometry (Flow Cyt) in Human samples. Trusted by the scientific community Anti-Myeloperoxidase [2C7] FITC (ab11729) was first used in a scientific publication in 2004 and has been cited over 10 times in peer-reviewed journals. Related products Antibody clone 2C7 is also available pre-conjugated to a variety of labels for your convenience – Anti-Myeloperoxidase FITC [2C7] (ab11729). Other related products We have a range of other formats of antibody clone [2C7] also available for your convenience: ab283263 , Carrier free - ab283284 , FITC - ab11729, PE - ab11730

FITC Anti-Myeloperoxidase antibody [2D4], Abcam, AB90812

What is this antibody validated in? FITC Anti-Myeloperoxidase antibody [2D4] (ab90812) is a mouse monoclonal antibody and is validated for use in Flow Cytometry (Intra), Flow Cytometry (Flow Cyt) in Mouse, Rat samples. Trusted by the scientific community Anti-Myeloperoxidase [2D4] FITC (ab90812) was first used in a scientific publication in 2010 and has been cited over 20 times in peer-reviewed journals. Related products Antibody clone 2D4 is also available pre-conjugated to a variety of labels for your convenience – Anti-Myeloperoxidase FITC [2D4] (ab90812). Other related products We have a range of other formats of antibody clone [2D4] also available for your convenience: ab90810 , FITC - ab90812

Biotin Anti-Myeloperoxidase antibody [2D4], Abcam, AB90811

Biotin Anti-Myeloperoxidase antibody [EPR20257], Abcam, AB322301

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-MPO/Myeloperoxidase Antibody (R1K13), AntibodySystem, RHC14802

Anti-MPO/Myeloperoxidase Antibody (R1K14), AntibodySystem, RHC14801

HRP Anti-Myeloperoxidase antibody [EPR20257], Abcam, AB323726

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

HRP Anti-Myeloperoxidase antibody [EPR4793], Abcam, AB306134

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

HRP Anti-Myeloperoxidase antibody [SP72], Abcam, AB305485

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-Myeloperoxidase antibody [MPO421-8B2], Abcam, AB269283